Smith & Nephew PLC

SN.: XLON (GBR)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
LOCK|X@?LOCK|&d%$wLOCK|@^Rkk>R

Smith & Nephew Earnings: The Turnaround Started Three Years Ago and Now Bears Fruit

Smith & Nephew reported second-quarter operational revenue growth of 7%, with orthopedics and sports medicine delivering solid mid-single-digit results while advanced wound management stood out with 10% year-over-year growth.

Sponsor Center